Literature DB >> 6713387

Incorporation of 5-fluorouracil into murine bone marrow DNA in vivo.

R C Sawyer, R L Stolfi, D S Martin, S Spiegelman.   

Abstract

Although 5-fluorouracil (FUra) is readily incorporated into RNA, the possibility of its being incorporated into DNA in substantial amounts has only recently been recognized. Examination of nucleic acids prepared from tumor-bearing BALB/c X DBA/8 F1 mice labeled with [3H]FUra in vivo revealed very little alkali-stable, acid-precipitable radioactivity in tumor and only small amounts in intestine. However, substantial amounts were detected in bone marrow. Pretreatment of mice with low-dose thymidine (500 mg/kg) increased the incorporation of FUra into RNA but did not change the amount incorporated into alkali-stable material. The net result was a reduction in the fraction of the total in an alkali-stable form. Formation of DNA containing FUra residues is substantially reduced if the mice receive very high doses of thymidine along with the labeled FUra, presumably through competition from an expanded deoxythymidine triphosphate pool. Bone marrow nucleic acids labeled with 32P and [3H]FUra were analyzed by cesium sulfate gradients. Two distinct peaks of tritium radioactivity were observed that band with 32P radioactivity at the densities of RNA and DNA. Pretreatment with alkali destroyed the (32P/3H)RNA peak, but not the DNA peak. Cesium sulfate-purified DNA containing FUra residues was digested with pancreatic DNase and venom phosphodiesterase. The resulting nucleotides were analyzed by high-pressure liquid chromatography. The majority of the radioactivity cochromatographed with 5-fluorodeoxyuridine monophosphate marker. No radioactivity was detected in the regions corresponding to fluorouridine monophosphate or deoxyuridine monophosphate, although radioactivity was detected cochromatographing with deoxythymidine monophosphate. After digestion with alkaline phosphatase, the majority of the radioactivity cochromatographed with fluorodeoxyuridine (and some thymidine). These results confirm previous observations of FUra incorporation into DNA of tissue culture cells.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6713387

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  12 in total

1.  DNA repair following incorporation of 5-fluorouracil into DNA of mouse bone marrow cells.

Authors:  J D Schuetz; H J Wallace; R B Diasio
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

2.  Targeting Histone Chaperone FACT Complex Overcomes 5-Fluorouracil Resistance in Colon Cancer.

Authors:  Heyu Song; Jiping Zeng; Shrabasti Roychoudhury; Pranjal Biswas; Bhopal Mohapatra; Sutapa Ray; Kayvon Dowlatshahi; Jing Wang; Vimla Band; Geoffrey Talmon; Kishor K Bhakat
Journal:  Mol Cancer Ther       Date:  2019-10-01       Impact factor: 6.261

3.  Effects of 5-fluorouracil on cytotoxicity and RNA metabolism in human colonic carcinoma cells.

Authors:  D A Greenhalgh; J H Parish
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

4.  Incorporation of pyrimidines and 5-fluoropyrimidines into normal tissues and an adenocarcinoma transplanted into the liver in rat.

Authors:  P I Christensson; C Erichsen; P E Jönsson; U Stenram
Journal:  J Cancer Res Clin Oncol       Date:  1985       Impact factor: 4.553

5.  Antitumor activity of FTC-092, a masked 5-trifluoromethyl-2'-deoxyuridine derivative.

Authors:  S Takeda; J Yamashita; H Saito; J Uchida; H Satake; Y Yamada; N Unemi; Y Wataya; H Hayatsu
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

6.  Experiments on the efficacy and toxicity of locoregional chemotherapy of liver tumors with 5-fluoro-2'-deoxyuridine (FUDR) and 5-fluorouracil (5-FU) in an animal model.

Authors:  R Bartkowski; M R Berger; J L Aguiar; T H Henne; J Dörsam; G H Geelhaar; P Schlag; C Herfarth
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

Review 7.  Participation of DNA repair in the response to 5-fluorouracil.

Authors:  M D Wyatt; D M Wilson
Journal:  Cell Mol Life Sci       Date:  2009-03       Impact factor: 9.261

8.  Continuous or bolus chemotherapy with 5-fluoro-2'-deoxyuridine in transplanted experimental liver tumors?

Authors:  T Riemenschneider; C Ruf; G Späth; G Stuhldreier; A Elmouaouy
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

9.  Mechanisms of collateral sensitivity to fluorouracil of a cis-diamminedichloroplatinum(II)-resistant human non-small lung cancer cell line.

Authors:  Y Sugimoto; Y Ohe; K Nishio; T Ohmori; T Morikage; Y Fujiwara; N Saijo
Journal:  Br J Cancer       Date:  1992-06       Impact factor: 7.640

10.  Molecular characterisation of two cell lines selected for resistance to the folate-based thymidylate synthase inhibitor, ZD1694.

Authors:  S J Freemantle; A L Jackman; L R Kelland; A H Calvert; J Lunec
Journal:  Br J Cancer       Date:  1995-05       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.